Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia (Q33335667)

25 July 2017

1 reference

title

Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia (English)

1 reference

heparin-induced thrombocytopenia

25 July 2017

0 references

1 reference

1 reference

Walenga JM

1

1 reference

25 July 2017

Jeske WP

series ordinal

2

1 reference

25 July 2017

Messmore HL

series ordinal

3

1 reference

25 July 2017

1 November 2000

1 reference

Journal of Thrombosis and Thrombolysis

25 July 2017

1 reference

25 July 2017

10 Suppl 1

1 reference

25 July 2017

13-20

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1027372901367

25 July 2017

0 references

cites work

Laboratory tests for heparin-induced thrombocytopenia: a multicenter study

1 reference

12 December 2020

Massive acute thrombosis of the descending thoracic aorta in heparin-associated thrombocytopenia and thrombosis

1 reference

12 December 2020

Arterial embolism occurring during systemic heparin therapy

1 reference

12 December 2020

Vascular damage correlates between heparin-induced thrombocytopenia and the antiphospholipid syndrome.

1 reference

12 December 2020

Determination of heparin-induced thrombocytopenia: a rapid flow cytometric assay for direct demonstration of antibody-mediated platelet activation.

1 reference

12 December 2020

Heparin-induced thrombocytopenic potential of GAG and non-GAG-based antithrombotic agents

1 reference

12 December 2020

Heparin-induced thrombocytopenia

1 reference

12 December 2020

Fc gamma RIIA H/R 131 polymorphism, subclass-specific IgG anti-heparin/platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis

1 reference

12 December 2020

Interactions of neutrophils and coagulation proteins.

1 reference

12 December 2020

P-selectin induction of tissue factor biosynthesis and expression

1 reference

12 December 2020

Platelet binding of IgG from patients with heparin-induced thrombocytopenia

1 reference

12 December 2020

Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia.

1 reference

12 December 2020

The biology of P-selectin glycoprotein ligand-1: its role as a selectin counterreceptor in leukocyte-endothelial and leukocyte-platelet interaction

1 reference

12 December 2020

Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia.

1 reference

12 December 2020

Platelet microparticles bind, activate and aggregate neutrophils in vitro

1 reference

12 December 2020

Heparin-induced thrombocytopenia: understanding improves but questions remain

1 reference

12 December 2020

The release mechanism of platelet-activating factor during shear-stress induced platelet aggregation

1 reference

12 December 2020

A diagnostic test for heparin-induced thrombocytopenia: detection of platelet microparticles using flow cytometry

1 reference

12 December 2020

Laboratory tests for the diagnosis of heparin-induced thrombocytopenia.

1 reference

12 December 2020

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

1 reference

12 December 2020

Mechanisms of cellular activation by platelet microparticles.

1 reference

12 December 2020

Thrombosis and inflammation as multicellular processes: significance of cell-cell interactions

1 reference

12 December 2020

Effect of glycoprotein IIb/IIIa antagonists on the HIT serum induced activation of platelets

1 reference

12 December 2020

Functional heterogeneity of antiheparin-platelet factor 4 antibodies: implications in the pathogenesis of the HIT syndrome.

1 reference

12 December 2020

Heparin-associated thrombocytopenia

1 reference

12 December 2020

Heparin-induced thrombocytopenia: historical review

1 reference

12 December 2020

Different platelet specificities of heparin-dependent platelet aggregating factors in heparin-associated immune thrombocytopenia

1 reference

12 December 2020

Heparin-induced thrombocytopenia with thrombosis: incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution

1 reference

12 December 2020

Adenosine diphosphate (ADP) and ADP receptor play a major role in platelet activation/aggregation induced by sera from heparin-induced thrombocytopenia patients

1 reference

12 December 2020

Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study

1 reference

12 December 2020

Endothelial cell hyperplasia contributes to thrombosis in heparin-induced thrombocytopenia.

1 reference

12 December 2020

Clinical experience with combined treatment of thrombin inhibitors and GPIIb/IIIa inhibitors in patients with HIT.

1 reference

12 December 2020

Neutrophil-platelet adhesion: relative roles of platelet P-selectin and neutrophil beta2 (DC18) integrins

1 reference

12 December 2020

Thrombin-activated human platelets release two NAP-2 variants that stimulate polymorphonuclear leukocytes

1 reference

12 December 2020

Simultaneous binding of heparin and platelet factor-4 to platelets: further insights into the mechanism of heparin-induced thrombocytopenia

1 reference

12 December 2020

Activation of platelets by sera containing IgG1 heparin-dependent antibodies: an explanation for the predominance of the Fc gammaRIIa "low responder" (his131) gene in patients with heparin-induced thrombocytopenia

1 reference

12 December 2020

Serum-induced platelet procoagulant activity: an assay for the characterization of prothrombotic disorders

1 reference

12 December 2020

Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen

1 reference

12 December 2020

HEPARIN--A CAUSE OF ARTERIAL EMBOLI?

1 reference

12 December 2020

Anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells

1 reference

12 December 2020

Single amino acid mutation of Fc gamma receptor is associated with the development of heparin-induced thrombocytopenia

1 reference

12 December 2020

Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells

1 reference

12 December 2020

Factor V Leiden and thrombotic complications in heparin-induced thrombocytopenia

1 reference

12 December 2020

Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant

1 reference

12 December 2020

Heparin-associated thrombosis despite normal platelet counts

1 reference

12 December 2020

Heparin-induced thrombocytopenia: laboratory studies

1 reference

12 December 2020

The procoagulant activity of red blood cells from patients with severe preeclampsia

1 reference

12 December 2020

Insights into heparin-induced thrombocytopenia.

1 reference

12 December 2020

Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets

1 reference

12 December 2020

Heparin-induced thrombocytopenia and thrombosis: clinical and laboratory studies

1 reference

12 December 2020

Effect of SR121566A, a potent GP IIb-IIIa antagonist, on the HIT serum/heparin-induced platelet mediated activation of human endothelial cells

1 reference

12 December 2020

12-Hydroxyeicosatetraenoic acid upregulates P-selectin-induced tissue factor activity on monocytes

1 reference

12 December 2020

Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia

1 reference

12 December 2020

A 14-year study of heparin-induced thrombocytopenia

1 reference

12 December 2020

Procoagulant expression in platelets and defects leading to clinical disorders

1 reference

12 December 2020

Selectins in the HIT syndrome: pathophysiologic role and therapeutic modulation

1 reference

12 December 2020

Platelet-derived microparticles associate with fibrin during thrombosis

1 reference

12 December 2020

Immune endothelial-cell injury in heparin-associated thrombocytopenia

1 reference

12 December 2020

Heparin-induced thrombocytopenia: the role of platelet activation and therapeutic implications.

1 reference

12 December 2020

Heparin-induced thrombocytopenia: mechanism of interaction of the heparin-dependent antibody with platelets

1 reference

12 December 2020

A global view on the role of monocytes and platelets in atherogenesis

1 reference

12 December 2020

P-selectin-beta 2-integrin cross-talk: a molecular mechanism for polymorphonuclear leukocyte recruitment at the site of vascular damage.

1 reference

12 December 2020

On the role of platelet Fc gamma RIIa phenotype in heparin-induced thrombocytopenia

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1027372901367

1 reference

Dimensions Publication ID

25 July 2017

0 references

1 reference